Notice: This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends LLIT vs. TTOO, STSS, BJDX, NAYA, VERO, AVGR, AFIB, INVO, DYNT, and NVIVQShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include T2 Biosystems (TTOO), Sharps Technology (STSS), Bluejay Diagnostics (BJDX), NAYA Biosciences (NAYA), Venus Concept (VERO), Avinger (AVGR), Acutus Medical (AFIB), INVO Bioscience (INVO), Dynatronics (DYNT), and Invivo Therapeutics (NVIVQ). These companies are all part of the "medical" sector. Lianluo Smart vs. T2 Biosystems Sharps Technology Bluejay Diagnostics NAYA Biosciences Venus Concept Avinger Acutus Medical INVO Bioscience Dynatronics Invivo Therapeutics T2 Biosystems (NASDAQ:TTOO) and Lianluo Smart (NASDAQ:LLIT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Is TTOO or LLIT more profitable? Lianluo Smart has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%. Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% Lianluo Smart N/A N/A N/A Does the MarketBeat Community prefer TTOO or LLIT? T2 Biosystems received 302 more outperform votes than Lianluo Smart when rated by MarketBeat users. However, 70.27% of users gave Lianluo Smart an outperform vote while only 63.04% of users gave T2 Biosystems an outperform vote. CompanyUnderperformOutperformT2 BiosystemsOutperform Votes40663.04% Underperform Votes23836.96% Lianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% Which has more volatility & risk, TTOO or LLIT? T2 Biosystems has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Do analysts rate TTOO or LLIT? T2 Biosystems currently has a consensus price target of $5.00, indicating a potential upside of 3,884.06%. Given T2 Biosystems' stronger consensus rating and higher possible upside, equities research analysts plainly believe T2 Biosystems is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings and valuation, TTOO or LLIT? Lianluo Smart has lower revenue, but higher earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.34-$50.08MN/AN/ALianluo Smart$380K2.26-$4.45MN/AN/A Does the media prefer TTOO or LLIT? In the previous week, T2 Biosystems had 2 more articles in the media than Lianluo Smart. MarketBeat recorded 2 mentions for T2 Biosystems and 0 mentions for Lianluo Smart. T2 Biosystems' average media sentiment score of 0.05 beat Lianluo Smart's score of 0.00 indicating that T2 Biosystems is being referred to more favorably in the media. Company Overall Sentiment T2 Biosystems Neutral Lianluo Smart Neutral Do insiders and institutionals hold more shares of TTOO or LLIT? 23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by insiders. Comparatively, 22.9% of Lianluo Smart shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryT2 Biosystems and Lianluo Smart tied by winning 7 of the 14 factors compared between the two stocks. Remove Ads Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$860,000.00$4.29B$5.63B$7.93BDividend YieldN/A39.85%4.89%4.05%P/E RatioN/A28.0423.6418.73Price / Sales2.2649.70371.04119.11Price / CashN/A51.0838.0534.64Price / Book-0.666.006.854.19Net Income-$4.45M$67.64M$3.19B$247.07M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$0.39+3.1%N/A-66.0%$860,000.00$380,000.000.006TTOOT2 Biosystems1.9558 of 5 stars$0.13-4.3%$5.00+3,687.9%-97.2%$2.78M$7.68M0.00180Analyst ForecastGap DownSTSSSharps Technology0.3285 of 5 stars$0.44+48.3%N/AN/A$2.42MN/A-0.053Short Interest ↑Gap UpHigh Trading VolumeBJDXBluejay Diagnostics0.2616 of 5 stars$4.15-1.0%N/A-98.8%$2.30M$250,000.000.009Short Interest ↑NAYANAYA BiosciencesN/A$0.30-2.9%$2.00+564.5%N/A$2.13M$6.23M0.0010News CoverageVEROVenus Concept0.7704 of 5 stars$2.76-8.9%N/A-65.6%$1.82M$67.20M-0.34410Short Interest ↑AVGRAvinger2.8672 of 5 stars$0.47flat$5.00+954.9%N/A$1.57M$7.26M-0.0470Upcoming EarningsAnalyst ForecastNews CoverageAFIBAcutus MedicalN/A$0.04-21.8%N/A-76.0%$1.25M$7.16M0.00340Gap DownINVOINVO BioscienceN/A$0.31+0.1%N/A-71.6%$1.18M$5.77M0.0025DYNTDynatronicsN/A$0.13-1.5%N/A-77.6%$1.17M$33.60M-0.16200Analyst ForecastNVIVQInvivo TherapeuticsN/A$0.37flatN/AN/A$1.15MN/A0.006High Trading Volume Remove Ads Related Companies and Tools Related Companies T2 Biosystems Competitors Sharps Technology Competitors Bluejay Diagnostics Competitors NAYA Biosciences Competitors Venus Concept Competitors Avinger Competitors Acutus Medical Competitors INVO Bioscience Competitors Dynatronics Competitors Invivo Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
